|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/02 | |
| A61K 39/00 | |||
| C12R 1/35 | |||
| C12N 1/20 |
| (11) | Number of the document | 2938356 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13821324.4 |
| Date of filing the European patent application | 2013-12-20 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/076803 |
| Date | 2013-12-20 |
| (87) | Number | WO 2014/105671 |
| Date | 2014-07-03 |
| (30) | Number | Date | Country code |
| 201261747026 P | 2012-12-28 | US |
| (72) |
JORDAN, Dianna M. Murphy, US
MARTINSON, Brian Thomas, US
MUEHLENTHALER, Christine Margaret, US
NEUBAUER, Axel, US
IYER, Arun V., US
|
| (73) |
Boehringer Ingelheim Vetmedica GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | IMMUNOGENIC COMPOSITION COMPRISING MYCOPLASMA ANTIGENS |
| IMMUNOGENIC COMPOSITION COMPRISING MYCOPLASMA ANTIGENS |